Diagnosis and management of red cell aplasia in children

B E Glader1

  • 1Department of Pediatrics, Stanford University School of Medicine, California.

Insights

Pediatric red blood cell aplasia (RBC aplasia) encompasses various conditions, including Diamond-Blackfan anemia and transient erythroblastopenia of childhood. Further research is needed to clarify the pathophysiology and long-term outcomes of these anemias.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Immunology

Background:

  • Pediatric red blood cell (RBC) hypoplastic anemias are primarily attributed to chronic hemolysis, Diamond-Blackfan anemia (DBA), and transient erythroblastopenia of childhood (TEC).
  • Other causes, mirroring adult RBC aplasia, include thymoma, anticonvulsant therapy, malnutrition, hepatitis, and leukemia treatment.
  • Many pediatric RBC aplasia cases lack a clear diagnosis, often considered variants of DBA, highlighting diagnostic challenges.

Purpose of the Study:

  • To address critical unanswered questions regarding the etiology, pathophysiology, and clinical course of pediatric RBC hypoplastic anemias.
  • To investigate the potential link between viral infections and RBC hypoplastic crises.
  • To differentiate between laboratory limitations and distinct disease entities within pediatric RBC aplasia.

Main Methods:

  • Review of existing literature and case reports on pediatric RBC aplasia.
  • Clinical observation of pediatric patients with various forms of RBC aplasia.
  • Analysis of diagnostic criteria and potential etiological factors.

Main Results:

  • The study highlights the heterogeneity of pediatric RBC aplasia, with common causes like DBA and TEC, and rarer associations with thymoma and specific therapies.
  • A case of a 16-year-old with pure RBC aplasia experiencing spontaneous remission is presented, raising questions about adolescent equivalents of TEC.
  • Significant diagnostic and etiological questions remain, particularly concerning the cellular pathophysiology of DBA and TEC and the potential for acute leukemia as a complication of DBA.

Conclusions:

  • Further research is essential to resolve key questions surrounding pediatric RBC hypoplastic anemias, including their pathophysiology, diagnostic criteria, and long-term prognosis.
  • The increasing incidence of TEC warrants further investigation into its causes and potential long-term implications.
  • Clarifying the distinct entities within pediatric RBC aplasia is crucial for accurate diagnosis and effective management.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...